Progyny (PGNY) EBITDA Margin (2018 - 2026)
Progyny's (PGNY) quarterly EBITDA Margin came in at 11.41% in Q2 2026, up 410.0% year-over-year from 2.24% in Q2 2025, and up 5.97% quarter-over-quarter from 10.77% in Q1 2026.
Analysis
Progyny (PGNY) EBITDA Margin (2018 - 2026) Analysis & Trends
Progyny (PGNY) has reported EBITDA Margin for 9 consecutive years, with 11.41% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA Margin rose 410.0% year-over-year to 11.41% in Q2 2026; TTM through Jun 2026 was 8.55%, a 237.0% increase from a year earlier, with the FY2025 full-year figure at 6.62%, up 84.0% from the prior year.
- EBITDA Margin was 11.41% for Q2 2026 at Progyny, up from 10.77% in the prior quarter.
- Over five years, EBITDA Margin peaked at 11.41% in Q2 2026 and troughed at 0.03% in Q1 2022.
- A 5-year average of 5.89% and a median of 5.64% in 2022 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin slumped 970 bps in 2022 and jumped 584 bps in 2023, its largest moves.
- Over 5 years, EBITDA Margin stood at 1.54% in 2022, then jumped by 231 bps to 5.11% in 2023, then rose by 3 bps to 5.29% in 2024, then retreated by 10 bps to 4.78% in 2025, then jumped by 139 bps to 11.41% in 2026.
- The last three EBITDA Margin figures came in at 11.41% (Q2 2026), 10.77% (Q1 2026), and 4.78% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Davita | 11.90 Bn | 11.21 Bn | 1.16 Bn | 16.29% |
| 2 | RadNet | 5.52 Bn | 4.79 Bn | 88.08 Mn | 6.34% |
| 3 | Fresenius Medical Care AG | 4.79 Bn | 4.09 Bn | 1.52 Bn | 9.58% |
| 4 | Concentra Group Holdings Parent | 4.28 Bn | 4.12 Bn | 192.10 Mn | 18.99% |
| 5 | Privia Health | 2.57 Bn | 2.16 Bn | - | 1.88% |
| 6 | Pediatrix Medical | 2.15 Bn | 1.74 Bn | - | 11.67% |
| 7 | Progyny | 2.12 Bn | 1.89 Bn | 89.30 Mn | 11.41% |
| 8 | Surgery Partners | 1.82 Bn | 1.61 Bn | 622.10 Mn | 12.03% |
| 9 | U S Physical Therapy | 1.17 Bn | 1.14 Bn | 41.94 Mn | 10.25% |
| 10 | Evolent Health | 468.17 Mn | 326.71 Mn | 80.84 Mn | -0.50% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.41% |
| Mar 31, 2026 | 10.77% |
| Dec 31, 2025 | 4.78% |
| Sep 30, 2025 | 6.87% |
| Jun 30, 2025 | 7.32% |
| Mar 31, 2025 | 7.46% |
| Dec 31, 2024 | 5.29% |
| Sep 30, 2024 | 4.35% |
| Jun 30, 2024 | 6.80% |
| Mar 31, 2024 | 6.66% |
| Dec 31, 2023 | 5.11% |
| Sep 30, 2023 | 6.48% |
| Jun 30, 2023 | 5.44% |
| Mar 31, 2023 | 5.81% |
| Dec 31, 2022 | 1.54% |
| Sep 30, 2022 | 5.48% |
| Jun 30, 2022 | 4.53% |
| Mar 31, 2022 | -0.03% |
| Dec 31, 2021 | -0.15% |
| Sep 30, 2021 | 7.41% |